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Guillain–Barré syndromeGangliosides are glycolipids mainly present at the plasma membrane (PM). Antibodies to gangliosides have
been associated with a wide range of neuropathy syndromes. Particularly, antibodies to GM1 ganglioside are
present in patients with Guillain–Barré syndrome (GBS). We investigated the binding and intracellular fate
of antibody to GM1 obtained from rabbits with experimental GBS in comparison with the transport of
cholera toxin (CTx), which binds with high afﬁnity to GM1. We demonstrated that antibody to GM1 is
rapidly and speciﬁcally endocytosed in CHO-K1 cells. After internalization, the antibody transited sorting
endosomes to accumulate at the recycling endosome. Endocytosed antibody to GM1 is recycled back to the
PM and released into the culture medium. In CHO-K1 cells, antibody to GM1 colocalized with co-
endocytosed CTx at early and recycling endosomes, but not in Golgi complex and endoplasmic reticulum,
where CTx was also located. Antibody to GM1, in contraposition to CTx, showed a reduced internalization to
recycling endosomes in COS-7 cells and neural cell lines SH-SY5Y and Neuro2A. Results from photobleaching
studies revealed differences in the lateral mobility of antibody to GM1 in the PM of analyzed cell lines,
suggesting a relationship between the efﬁciency of endocytosis and lateral mobility of GM1 at the PM. Taken
together, results indicate that two different ligands of GM1 ganglioside (antibody and CTx) are differentially
endocytosed and trafﬁcked, providing the basis to gain further insight into the mechanisms that operate in
the intracellular trafﬁcking of glycosphingolipid-binding toxins and pathological effects of neuropathy-
associated antibodies.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Gangliosides are acidic complex glycosphingolipids synthesized in
the lumen of the Golgi complex. After their synthesis, gangliosides
leave the Golgi complex via the lumenal surface of exocytic transport
vesicles that move to and fuse with the plasmamembrane (PM) [1–4].
At the PM, gangliosides participate in cell surface events such as
modulation of growth factor receptors and cell-to-cell and cell-to-
matrix interactions [5–14]. It has been also demonstrated that sphi-
ngolipids in general and glycosphingolipids in particular are differen-
tially required for clathrin-independent endocytosis [10,15,16]. In
addition, the correct balance of glycosphingolipids in endomembraneslera toxin; CTxB, cholera toxin
o's modiﬁed Eagle's medium;
ter photobleaching; GalNAc-T,
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iotti).
ll rights reserved.is essential for the proper function of exocytic and endocytic trafﬁcking
[17–20].
Information on intracellular trafﬁcking of endogenously synthe-
sized glycolipids has been lacking owing to the methodological
difﬁculties of studying their transport. Consequently, lipid sorting has
been analyzed using ﬂuorescent-labeled lipid analogues, labeled
toxins or radioactive-labeled lipids [21]. In this sense, ganglioside
GM1 endocytic transport has been studied principally by the use of
cholera toxin (CTx) [6,22]. CTx belongs to the family of AB5 toxins and
binds up to ﬁve molecules of GM1 at a time via its B subunits (CTxB).
Ganglioside GM1 has been suggested to be the vehicle that directs the
toxin to its ﬁnal intracellular destination [6,23]. CTx is internalized to
endosomes and then sorted to the trans-Golgi network (TGN) and
endoplasmic reticulum (ER). If the endocytic pathways of CTx and
exogenous added GM1 (ﬂuorescent- or radioactive-labeled GM1) are
pathways followed by endogenous GM1 remains to be established.
We recently used an antibody binding technique to study the
intracellular fate of internalized ganglioside GD3 [24]. We demons-
trated that a mouse monoclonal antibody to GD3 was speciﬁcally
endocytosed bound to the ganglioside, sorted to early and recycling
endosomes and transported back to the PM by clathrin-coated
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associated with neuropathologic syndromes, like Guillain–Barré syn-
drome (GBS) [5,25–28]. Neither internalization nor intracellular des-
tination of neuropathy-associated antibodies to gangliosides has so far
been extensively explored.
The aim of this study was to investigate cellular binding and
endocytic destination of neuropathy-associated antibody to GM1
ganglioside in comparison with CTx. Antibody to GM1 (IgG and
IgM classes) was obtained from rabbits with experimental GBS
induced by sensitization with GM1 ganglioside [25,26]. Results
obtained by biochemical and ﬂuorescent confocal techniques
clearly suggest a differential endocytic trafﬁcking of antibody to
GM1 ganglioside and CTx in different cell types.
2. Materials and methods
2.1. Cell culture, plasmids and DNA transfection
The following cells were used: wild-type Chinese hamster ovary
(CHO)-K1 cells (ATCC, Manassas, VA); CHO-K1GM1+, a double-
stable transfectant expressing UDP-GalNAc:LacCer/GM3/GD3 N-
acetylgalactosaminyltransferase (GalNAc-T) and UDP-Gal:GA2/GM2/
GD2 galactosyltransferase (Gal-T2), which synthesize GM1 and GD1a
(clone 2, [29]); neuroblastoma cell lines Neuro2A and SH-SY5Y
(ATCC); and COS-7 cells. CHO-K1, COS-7 and Neuro2A cells were
grown and maintained at 37 °C in 5% CO2 in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and antibiotics. SH-SY5Y cells were grown and maintained at
37 °C in 5% CO2 in Dulbecco's modiﬁed Eagle's medium-F12 (DMEM/
F-12) supplemented with 10% FBS and antibiotics. Expression
plasmids for Rab11a-green ﬂuorescent protein (GFP), GFP-Rab5 and
GalNAc-T fused to yellow ﬂuorescent protein (YFP) were already
described [24]. Themajor histocompatibility complex class II invariant
chain isoform (Iip-33) fused to GFP was gratefully received from H.J.F.
Maccioni (CIQUIBIC, National University of Córdoba, Argentina).
Expression plasmid for caveolin-1–GFP was generously received
from M. Pagac (Institute of Biochemistry, ETH Zurich, Zurich,
Switzerland). Transient transfections were carried out with 1 μg of
DNA per 35-mm dish using cationic liposomes (Lipofectamine; Invi-
trogen, Carlbad, CA) essentially according to the manufacturer's ins-
tructions and incubated for 24 or 72 h (for caveolin-1–GFP
expression) at 37 °C with the transfection reagent and DNA mixture.
2.2. Preparation of GM1 afﬁnity column and antibody puriﬁcation
and labeling
For preparation of GM1 afﬁnity column, 1.5 ml methanol-aqueous
0.2 M KCl (1:1) containing 250 nmol GM1 was added to 1 ml octyl-
Sepharose CL-4B (Sigma-Aldrich, St. Louis, MO). The mixture was
rotated end-over-end at room temperature for 12 h, the solution was
removed, and the gel was washed three times with 5 volumes of
phosphate-buffered saline (PBS). The remaining steps were per-
formed at 4 °C. Small portions of gel were loaded in calibrated
columns and washed with PBS [30]. Antibody to GM1 was obtained
from GBS rabbits [25] and puriﬁed by afﬁnity chromatography.
Brieﬂy, sera were diluted 1:1 with PBS and applied to the GM1-octyl-
Sepharose CL-4B column. After washing with PBS, antibody to GM1
(IgG and IgM isotype) was eluted with KSCN 3M, and, immediately,
applied to a Sephadex-G25 (Sigma-Aldrich) column for buffer
exchange with PBS. Antibody was then concentrated with Centri-
con-10 (Amicon, MA). For IgG and IgM puriﬁcation, antibody eluted
from Sephadex-G25 column was applied to a protein G column
(HITRAP protein G HP, GE Healthcare Bio-Sciences, Piscataway, NJ)
essentially according to the manufacturer's instructions. IgM anti-
body does not bind to protein G, so it passes through the column. IgG
antibody binds to the protein G column and is recovered in theelution buffer. After puriﬁcation, IgG and IgM antibodies were con-
centrated by Centricon-10. Antibody purity and molecular mass was
controlled by SDS-PAGE electrophoresis under reducing and non-
reducing conditions and Coomassie-Blue staining and Western
blotting. For ﬂuorescent labeling, antibody to GM1 was labeled
with Alexa488 using the Alexa Fluor® 488 Monoclonal Antibody
Labeling Kit (Molecular Probes, Eugene, OR) according to the manu-
facturer's instructions.
2.3. Cell labeling and internalization assays
Cells transiently transfected or not with plasmids indicated above
were incubated at 4 °C (on ice) for 10 min to inhibit intracellular
transport. Then, cells were incubated for another 45 min at 4 °C with
antibody to GM1 in conjunction or not with Alexa555–CTxB
(Molecular Probes, 0.2 μg/ml), or with CTx (Sigma-Aldrich, 2 μg/ml)
in order to label GM1 ganglioside present at the cell surface.
Afterwards, cells were washed three times with cold PBS and
harvested or ﬁxed or transferred to 37 °C with fresh prewarmed
complete DMEM or DMEM/F-12 to allow endocytic transport for
different times, and ﬁnally harvested by scraping or ﬁxed in 4%
paraformaldehyde in PBS for 30 min at room temperature (RT). For
transferrin (Tf) internalization, cells were ﬁrst incubated for 60 min
in culture medium without FBS, then incubated at 4 °C in cold culture
medium containing 10 μg/ml Alexa647–Tf (Molecular Probes) and
antibody to GM1 or CTx for 45 min, and then transferred to 37 °C
with prewarmed culture medium without FBS, supplemented with
10 μg/ml Alexa647–Tf and processed at different times. For lysosome
staining, cells were incubated in DMEM without FBS supplemented
with 0.2 μM acidotropic probe LysoTracker Red DND-99 (Molecular
Probes) for 15 min at 37 °C before ﬁxation. When indicated, antibody
to GM1 or CTx remaining at the cell surface was removed by acid
stripping with acetate buffer pH 3.6 containing 0.5 M NaCl, at 4 °C for
3 min.
2.4. Recycling assay of antibody to GM1
CHO-K1GM1+ cells were incubated at 16 °C for 10 min and then
with antibody to GM1 (IgG or IgM) for another 60 min at 16 °C to
allow endocytosis to early endosomes. Cell surface-bound antibody
was then removed by acid stripping at 4 °C, and cells were extensively
washed with cold PBS. Then, they were incubated at 37 °C with
prewarmed fresh culture medium without FBS in order to restore
transport of internalized antibody. Cells and culture medium were
recovered at different times. Proteins from the culture medium were
precipitated with chloroform/methanol (1:4, v/v) and resuspended
in PBS. The presence of antibody (IgG or IgM classes) in cells and
culture medium was assessed by Western blotting.
2.5. Assay of CTx induced morphological change in CHO-K1GM1+ cells
The assay was carried out as previously described [31] with
minor changes. Brieﬂy, CHO-K1GM1+ cells were harvested and
transferred to 35-mm dishes with coverslips. After 3 h, DMEM
with 10% FBS was added supplemented or not with CTx (2 μg/ml).
Coverslips were ﬁxed at different times with 4% paraformaldehyde
at RT during 15 min and examined microscopically to determine the
percentage of cells with morphological changes. Untreated or non-
responding cells are round while those cells treated with CTx show
polymorphic shape changes, as bipolarity and branching [31]. More
than 500 cells were counted per each time.
2.6. Electrophoresis and Western blotting
Proteins were resolved by electrophoresis in 10% polyacrylamide
gels under reducing or non-reducing conditions and then transferred
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immunoblotting, non-speciﬁc binding sites on the nitrocellulose
membrane were blocked with 5% defatted dry milk in 400 mM
NaCl/100 mM Tris–HCl pH 7.5 buffer (TBS). A rabbit serum against
CTx (generated in our laboratory) was used at a dilution of 1:1500.
Antibody to GM1 and antibody to CTx were detected using protein A
coupled to horseradish peroxidase and combined with a chemilumi-
nescence detection kit (SuperSignal West Pico Chemiluminescent
Substrate, Pierce, IL) and Hyperﬁlm MP ﬁlms (GE Healthcare, Little
Chalfont, UK), or by using near-infrared ﬂuorescence (LI-COR
Biotechnology, Lincoln, NE) with goat anti-rabbit coupled to
IRDye800CW (LI-COR Biotechnology). Blot values were corrected
using their corresponding α-tubulin levels detected with monoclonal
anti-α-tubulin clone DM1A (Sigma-Aldrich) diluted at 1:5000.
Molecular mass was calculated based on calibrated standards
(BenchMark prestained protein ladder; Invitrogen) run in every gel.
The relative contribution of individual bands was calculated using the
computer software Odyssey Application Software v2.1 (LI-COR
Odyssey). Final images were compiled with Adobe Photoshop 9.0.
2.7. Confocal immunoﬂuorescence microscopy and colocalization
analysis
Cells grown on coverslips were washed twice with PBS, ﬁxed
with 4% paraformaldehyde in PBS at room temperature for 30 min
and permeabilized when necessary with 0.1% saponin/2% BSA in
PBS at room temperature for 15 min. Then, cells were washed with
PBS and exposed to secondary antibodies at 37 °C for 90 min.
Secondary antibodies were Alexa488-conjugated goat anti-rabbit
(Molecular Probes) or rhodamine-conjugated goat anti-rabbit IgG
(Jackson ImmunoResearch Laboratories, Inc., Pennsylvania) or
TRITC-conjugated goat anti-human IgG (Sigma-Aldrich), diluted
1:1000. Secondary goat antibodies react with IgG heavy chains
and all classes of immunoglobulin light chains from rabbit, so they
react with both IgG and IgM antibody to GM1. Anti-human
antibodies were speciﬁc for IgG. Cells were mounted in FluorSave
reagent (Calbiochem, EMD Biosciences, La Jolla, CA). Confocal
images were collected using a Carl Zeiss LSM5 Pascal laser-scanning
confocal microscope (Carl Zeiss, Jena, Germany) equipped with an
argon/helium/neon laser and a 60×1.4 numerical aperture, oil
immersion objective (Zeiss Plan-Apochromat), or with an Olympus
FluoView™ FV1000 confocal microscope equipped with an argon/
helium/neon laser and a 100×1.4 numerical aperture, oil immer-
sion objective. Single confocal sections of approximately 0.7 μm
were taken parallel to the coverslip (xy sections). Images were
acquired and processed with the Zeiss LSM image software or
Olympus FluoView FV10-ASW software. Final images were compiled
with Adobe Photoshop 9.0. The ﬂuorescence micrographs shown in
this manuscript are representative of at least three independent
experiments. Average ﬂuorescence intensity was quantiﬁed using
ImageJ software (Rasband, W.S., ImageJ, US National Institutes of
Health, Bethesda, Maryland, http://rsb.info.nih.gov/ij/, 1997–
2008.). Pearson's coefﬁcient (Pearson's r) was calculated using
ImageJ software with the JACoP plugin [32]. A Pearson's rN0.6 was
considered signiﬁcant.
2.8. Live cell imaging and ﬂuorescence recovery after photobleaching
(FRAP) studies
For recycling endosome colocalization analysis Alexa488–antibody
to GM1 (diluted at 1:40) and CTxB subunit–Alexa555 (0.2 μg/ml, 16
pM) were applied to CHO-K1GM1+ cells grown in LabTek II coverglass
at 4 °C for 45 min in phenol red-free DMEM, and then for 30 min at
37 °C in 5% CO2. Confocal stacks were acquired on FluoView™ FV1000
confocal microscope with 100× UPlanSApo oil immersion/1.4 NA
objective (Olympus, Japan), using a pinhole appropriate to obtain 1 μmoptical slices and 40× digital zoom for acquiring recycling endosomes
stacks. FRAP experiments were performed in an Olympus FluoView
FV1000 confocal microscope using a 40× UPlanFLNBPFP1 oil immer-
sion/1.3 NA objective (Olympus, Japan) using a pinhole appropriate to
obtain 4 μm optical slices. Cells grown in LabTek II coverglass were
incubated with Alexa488–antibody to GM1 at 4 °C for 20 min in phenol
red-free DMEM. Then, unbound antibody was washed away, and cells
were transferred at 22 °C to the microscope. Pre- and post-bleaching
images (10 and 500 images, respectively) were acquired each 0.4 s.
Bleaching was carried out using 30× digital zoom, 4-μm-diameter
circular bleach region (1024 pixels×1024 pixels resolution), 20 μs/
pixel direct scan, 100% transmission of both 458 and 488 nm laser lines
(30 mW). Bleaching time was less than 10 s and ﬂuorescence of
Alexa488 after bleaching was lower than 10% of its initial value. The
average ﬂuorescence intensities of the bleached area, background and
whole cell were measured with Olympus FluoView FV1000 software
(v 1.7.1.0) and data was normalized as already described [33], except
that in every case ﬂuorescence value after photobleaching was set as
cero. Movile fraction and the half time of recovery (t1/2) were
calculated with Origin software (version 5.2, Microcal Software, Inc.,
Northampton, MA) using a simple diffusion function (equation 12,
[34]). Diffusion coefﬁcient (D) was calculated from the half time of
recovery (t1/2) and bleach radius (w) as described [33,35,36].
Signiﬁcance was determined by a t test. For presentation purposes
the ﬂuorescence intensity curve was smoothed by adjacent averaging
of ﬁve points (approximately 2 s interval). No signiﬁcant photorever-
sibility of Alexa488 was observed in FRAP experiments using cells ﬁxed
with 4% paraformaldehyde for 20 min at room temperature.
2.9. Total internal reﬂection ﬂuorescence microscopy (TIRFM)
CHO-K1GM1+ cells were incubated at 4 °C for 10 min and then
with Alexa488–antibody to GM1 (diluted at 1:40) and CTxB subunit–
Alexa555 (0.2 μg/ml) for another 45 min at 4 °C. Then, cells were
ﬁxed in 4% paraformaldehyde in PBS for 30 min at room temperature
(PM staining) or incubated at 37 °C for 10 min in order to restore
transport. Cell surface-bound antibody was then removed by acid
stripping at 4 °C, and cells were extensively washed with cold PBS
and ﬁxed (endocytic vesicles staining). TIRFM was carried out in a
fully motorized Nikon TE-2000 E inverted microscope (Nikon
Instruments, Inc., Melville, NY) equipped for DIC, epiﬂuorescence
and TIRFM, using a 100× oil immersion objective, an ORCA II ER
camera (Hamamatsu Photonics K.K., Hamamatsu City, Japan) and
Metamorph software (Universal Imaging, West Chester, PA).
3. Results
3.1. Neuropathy-associated antibody to GM1 is speciﬁcally internalized
in CHO-K1GM1+ cells
Antibody to GM1 was obtained from GBS rabbits and puriﬁed by
afﬁnity chromatography. Unless a speciﬁc antibody class is indicated,
“antibody to GM1” refers to afﬁnity puriﬁed antibody containing IgG
and IgM immunoglobulins. Binding and speciﬁcity of the polyclonal
antibody was tested for immunoreactivity against GM1, structurally
related glycolipids and glycolipids puriﬁed from the studied cell lines
(CHO-K1GM1+, COS-7, Neuro2A and SH-SY5Y) by TLC immunostain-
ing. The antibody speciﬁcally bound to GM1 ganglioside and only
slightly to GD1b and GA1 (Fig. S1A), as already described [25,26]. On
the other hand, the antibody only showed reactivity against GM1 in
all studied cell lines (Fig. S1B).
In order to investigate transport and intracellular fate of antibody
to GM1, we used a CHO-K1 cell line genetically modiﬁed to express
GM1 (CHO-K1GM1+) by stable expression of GalNAc-T and Gal-T2
[29]. First, we characterized membrane binding and internalization
of antibody to GM1 following essentially the already described
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GD3 ganglioside [24]. Brieﬂy, CHO-K1GM1+ and wild-type CHO-K1
(CHO-K1WT) cells were incubated at 4 °C to inhibit intracellular
transport and then with antibody to GM1 at 4 °C during 45 min to
allow membrane binding. Next, cells were washed, ﬁxed or trans-
ferred to 37 °C to allow endocytic transport. Confocal microscopy
analysis revealed that the antibody to GM1 bound to the PM of CHO-
K1GM1+ cells (Fig. 1A, 45 min 4 °C). After incubation at 37 °C, the
antibody to GM1 was internalized by CHO-K1GM1+ cells and accu-
mulated in a perinuclear area, resembling the Golgi complex or
recycling endosomes, and distributed in punctuate structures around
the cytoplasm (Fig. 1A, 30 min 37 °C). At 60 and 120 min after the
beginning of the endocytosis, the perinuclear accumulation of
antibody to GM1 in CHO-K1GM1+ cells was not longer evident, and
some antibody remained associated with vesicular structures all
over the cytoplasm (Fig. 1A, 60 and 120 min 37 °C). It should be
mentioned that the perinuclear accumulation of antibody was still
evident after 60 min of endocytosis when the antibody was cons-
tantly present in the cell culture medium (results not shown). On
the other hand, CHO-K1WT cells, which only express the GM3
ganglioside, did not bind (Fig. 1B, 45 min 4 °C) and internalize
antibody to GM1 (Fig. 1B, 30 min 37 °C, left panel), but they did
internalize the endocytic marker Tf (Fig. 1B, 30 min 37 °C, right
panel). Altogether, the results show that polyclonal antibody to GM1
is internalized in CHO-K1GM1+ cells and this internalization is
mediated speciﬁcally by binding to GM1 ganglioside.
3.2. Internalized antibody to GM1 is targeted to recycling endosomes but
not to lysosomes, TGN or ER in CHO-K1GM1+ cells
To characterize the intracellular fate of endocytosed antibody to
GM1, we performed a colocalization analysis with markers of the
endocytic and exocytic pathways. We found that internalized antibody
did not colocalizewith LysoTracker Red, amarker of lysosomes, after 30,
60 or 120 min after the beginning of endocytosis (Fig. 2B and Fig. S2A).Fig. 1. Binding an internalization of antibody to GM1 in CHO-K1 cells. (A) CHO-K1GM1+ cells w
4 °C during 45 min to allow membrane binding. Next, cells were washed, ﬁxed (45 min 4 °C
Representative confocal sections of 1 μm from the different times taken parallel to the covers
were incubated at 4 °C to inhibit intracellular transport and thenwith antibody to GM1 (Ab to
(45min 4 °C) or transferred to 37 °C inmedia with Alexa647–Tf (as a positive control of endoc
by using Alexa488-conjugated goat anti-rabbit IgG. Representative confocal sections of 1 μmOn the other hand, we observed that antibody to GM1 extensively
colocalized with co-endocytosed Tf, a marker of the perinuclear
recycling endosomes, after 30 min (Fig. 2A) of the beginning of
endocytosis. However, a signiﬁcant decrease of colocalization was
observed after 60 and 90min (Fig. S2B). No colocalizationwas observed
at any given timeof endocytosis (30, 60 and 120min)between antibody
to GM1 and GalNAc-T fused to YFP, a TGN marker [37–39] (Fig. 2C, at
60min), or Iip33, an ERmarker (Fig. 2D, at 120min). Although TGN and
recycling endosomes are organelles located very close to each other in
the peri-centrosome area, the speciﬁc organelle markers used in this
study do not signiﬁcantly colocalized (Fig. S2C). Taken together, these
data indicate that internalized antibody to GM1 is sorted to recycling
endosomes but not to lysosomes or organelles from the exocytic
pathway as the TGN and ER.
3.3. Antibody (IgG and IgM) to GM1 is recycled back to the PM after
internalization in CHO-K1GM1+ cells
Wepreviously described that an internalizedmonoclonal antibody
to GD3 ganglioside was recycled back to the PM and released to the
culture medium after transiting endocytic compartments [24]. In
order to explore if the internalized polyclonal antibody to GM1 was
also recycled to the PM, CHO-K1GM1+ cells were incubated with the
antibody at 16 °C during 1 h, which allow endocytic cargo to accumu-
late in sorting endosomes. Then, cells were acid stripped to remove
the remaining antibody at the PM (at this time cells only contained
antibody in endocytic compartments) and temperature shifted to
37 °C to allow further transport and recycling in fresh culturemedium.
Cells and culture medium were harvested at 30, 60 and 120 min
and analyzed for the presence of antibody to GM1 by Western
blotting. As shown in Fig. 3A and B, both IgG and IgM antibodies
accumulated in the cells at 16 °C (0 min). At 30, 60 and 120 min
the antibodies were recovered from the culture medium, remaining
a fraction associated with the cells. The antibody that recovered
from the extracellular medium was found to have the expectedere incubated at 4 °C to inhibit intracellular transport and thenwith antibody to GM1 at
) or transferred to 37 °C to allow endocytic transport for 30, 60 and 120 min and ﬁxed.
lip are shown. Insets in panels show details at higher magniﬁcation. (B) CHO-K1WT cells
GM1) at 4 °C during 45min to allowmembrane binding. Next, cells were washed, ﬁxed
ytosis) to allow endocytic transport for 30min and ﬁxed. Antibody to GM1was detected
from the different times taken parallel to the coverslip are shown. Scale bars: 10 μm.
Fig. 2. Internalized antibody to GM1 is targeted to sorting and recycling endosomes but not to lysosomes, TGN or ER in CHO-K1GM1+ cells. Non-transfected CHO-K1GM1+ cells (A and
B) or transiently expressing the TGN marker GalNAc-T–YFP (C, pseudo-colored green) or the ER marker Iip33–GFP (D) were incubated at 4 °C to inhibit intracellular transport and
then with antibody to GM1 (Ab to GM1) at 4 °C during 45 min to allow membrane binding. Next, cells were transferred to 37 °C to allow endocytic transport for 30 min (A and B),
60 min (C) or 120 min (D) and ﬁxed. For recycling endosome labeling (A), cells were incubated with Alexa647–Tf (Alexa647–Tf, pseudo-colored green) at 37 °C during 30 min. For
lysosome staining (B), cells were incubated with 0.2 μMof the acidotropic probe LysoTracker Red DND-99 at 37 °C for 15min before ﬁxation. Antibody to GM1was detected by using
rhodamine-conjugated goat anti-rabbit IgG. Expression of GalNAc-T and Iip33 was detected by the intrinsic ﬂuorescence of YFP and GFP, respectively. Representative confocal
sections of 1 μm taken parallel to the coverslip are shown. Insets in merge panels show details at higher magniﬁcation. Scale bars: 10 μm.
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that puriﬁed IgM and IgG antibodies to GM1 followed almost the same
intracellular itinerary (Fig. S3). Taken together, these results show
that, after being internalized, both IgG and IgM antibodies to GM1 are
recycled back to the PM and released into the culture medium.
3.4. Endocytic transport of CTx in CHO-K1GM1+ cells
At this point, it results evident that the intracellular fate of
endocytosed antibody to GM1 is quite different from that described
for CTx in different cell lines [6,23]. CTx is targeted to the Golgi
complex and ER while the antibody to GM1 is internalized to
recycling endosomes and then recycled back to the PM in CHO-
K1GM1+ cells (Figs. 2 and 3).
As CHO-K1WT cells do not synthesize GM1 ganglioside, intracel-
lular transport of CTx has not been studied so far in this cell line. Thus,we analyzed the endocytic fate and transport of CTx in genetically
modiﬁed CHO-K1 cells which endogenously synthesize GM1 gangli-
oside (CHO-K1GM1+). To track the endocytic fate of CTx we used the
CTxB tagged with a ﬂuorescent tag or the complete toxin (AB5),
following essentially the same protocols used to study the internal-
ization of antibody to GM1. CTx speciﬁcally bound to CHO-K1GM1+
cells and not to CHO-K1WT cells, as assessed by Western blotting
analysis (Fig. 4A). Using confocal ﬂuorescent microscopy analysis and
colocalization with different organelle markers, we found that CTxB
was internalized to early endosomes (15 min at 37 °C), only partially
colocalizing with Rab5 positive endosomes (result not shown). At
30min, internalized CTxB accumulated in a perinuclear compartment,
colocalizing with Tf and the GTPase Rab11a fused to GFP, twomarkers
of recycling endosomes (Fig. 4B, ﬁrst and second row, respectively). At
60min, internalized CTxB colocalized with GalNAc-T–YFP, a marker of
the TGN (Fig. 4B, third row). At longer times of internalization
Fig. 3. Antibody to GM1 (IgG and IgM classes) is recycled back to the PM after internalization in CHO-K1GM1+ cells. CHO-K1GM1+ cells were incubated at 16 °C for 10 min and then
with IgG (A) or IgM (B) antibody to GM1 (Ab to GM1) for another 60 min at 16 °C to allow endocytosis to early endosomes. Cell surface-bound antibody was then removed by acid
stripping at 4 °C, and cells were extensively washed with cold PBS. Cells were then incubated at 37 °C with prewarmed culture medium to restore transport of internalized antibody
and cells (C) and culture medium (M) were recovered at different times. The presence of antibody (IgG and IgM classes) in both samples was analyzed by Western blotting under
non-reducing conditions. Graphs show the relative contribution of bands in each condition. The sum of band intensities (C+M) at each time was taken as 1.
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the marker Iip33–GFP (Fig. 4B, fourth row). These results indicate that
CTxB follows a retrograde intracellular pathway in CHO-K1GM1+
similar to that described in cells that endogenously express GM1
ganglioside. To further demonstrate that CTx is properly targeted and
functionally active in CHO-K1GM1+ cells we measured morphological
changes in response to the increase of cellular cyclic-AMP mediated
by CTx, as already reported [31,40]. Untreated CHO-K1GM1+ cells
showed a rounded phenotype (Fig. 4D, left picture) while CTx-treated
CHO-K1GM1+ cells showed polymorphic shape changes, as bipolarity
and branching (Fig. 4D, right picture). The quantiﬁcation of the
morphological changes induced by CTx is shown in Fig. 4C. Altogether,
these results indicate that CTx treatment of CHO-K1GM1+ cells signi-
ﬁcantly affect their morphology, indicating that CTx is active and
properly targeted in this cell line.
3.5. Internalized antibody to GM1 and CTxB partially colocalize in sorting
and recycling endosomes in CHO-K1GM1+ cells
As observed above, two different GM1 binding proteins have a
different intracellular itinerary after being endocytosed in CHO-
K1GM1+ cells. In order to simultaneously track internalization and
intracellular fate of antibody to GM1 and CTx, CHO-K1GM1+ cells were
incubated at 4 °C to inhibit intracellular transport and then with anti-
body to GM1 and CTxB at non-saturating concentrations at 4 °C for
45 min to allow membrane binding. Then, cells were washed, ﬁxed or
transferred to 37 °C in order to reestablish endocytic transport. At 4 °C,
antibody toGM1andCTxBbound thePMofCHO-K1GM1+cells (Fig. 5A).
After 30 min of internalization at 37 °C, we observed a signiﬁcant
colocalization (Pearson's r: 0.88±0.04) of antibody to GM1 with CTxB
in Tf-positive recycling endosomes (Fig. 5C). To explore colocalization
of these molecules in early endosomal compartments, cells were incu-
batedwith antibody to GM1 and CTxB at 16 °C to accumulate endocytic
cargos at the early endosomes. As shown in Fig. 5B, under this experi-
mental condition the antibody to GM1 and CTxB only partially colo-
calized (Pearson's r: 0.67±0.02) in vesicles at the early endosomes.
We next considered that the tubular–vesicular structure of the
recycling endosomes could be sensitive to ﬁxation and permeabi-lization techniques. To avoid this process, we performed an in vivo
analysis of colocalization between Alexa555–CTxB and Alexa488–
antibody to GM1. Cells were incubated with both proteins for
30 min at 37 °C and then ﬂuorescent confocal sections (xy) of the
recycling endosomes were acquired. Fig. 5D shows a xy confocal
section from a z stack of the recycling endosomes in two different
CHO-K1GM1+ cells. Colocalization was evident in some regions of
the organelle (Fig. 5D, arrowhead number 3). However, we found
regions into the recycling endosomes where antibody to GM1 and
CTxB did not colocalize (Fig. 5D, arrowheads 1, 5 and 6) and also
vesicles around the organelle carrying only one of the GM1 binding
proteins (Fig. 5D, arrowheads 2 and 4), indicating a segregation of
both markers at the recycling endosomes.
To further examine PM distribution and internalization of GM1
ligands at earliest endosomal compartments (vesicles close to the cell
surface), TIRFM experiments were performed in CHO-K1GM1+ cells.
Cells were incubated at 4 °C with antibody to GM1 and CTxB at non-
saturating concentrations and then transferred to 37 °C during 10 min
in order to reestablish endocytic transport.We observed that antibody
to GM1 and CTxB are differentially distributed at the PM (Fig. 6A).
More interesting, no signiﬁcant colocalization was detected between
antibody to GM1- and CTxB-containing structures after the short
period of uptake (Pearson's r: 0.49±0.05) (Fig. 6B). Thus, taken into
consideration these results and the extent of overlapping of GM1
ligands at early endosomes (see Fig. 5B) it is highly probable that
antibody to GM1 and CTxB are mainly internalized in separate endo-
somes that later fuse with early endosomes and trafﬁc to recycling
endosomes.
Next, we tested separately the binding of IgG and IgM to GM1 in
cells previously incubated with different concentrations of CTx in
order to investigate if antibody to GM1 and CTx bind to the same pool
of GM1 at the PM. When CHO-K1GM1+ cells were preincubated with
CTx at non-saturating concentrations (20 nM, Fig. S4A), cell binding of
IgG and IgM classes of antibody to GM1 was only slightly reduced
(CTx 20 nM, Fig. S4B and C). On the other hand, when cells were
incubated with saturating concentrations of CTx (100 nM, Fig. S4A),
binding of IgG and IgM classes of antibody to GM1 was signiﬁcantly
reduced (CTx 100 nM, Fig. S4B and C). These results indicate that CTx
Fig. 4. Endocytic transport of CTx in CHO-K1GM1+ cells. (A) CHO-K1GM1+ cells and CHO-K1WT cells were incubated with (+) or without (−) 2 μg/ml of CTx at 4 °C during 45 min to
allowmembrane binding. Next, cells were washed and harvested by scrapping. Presence of CTx was analyzed byWestern blotting. (B) Non-transfected CHO-K1GM1+ cells (ﬁrst row)
or transiently expressing the recycling endosome marker Rab11–GFP (second row), TGN marker GalNAc-T–YFP (third row, pseudo-colored green) or ER marker Iip33–GFP (fourth
row)were incubated at 4 °C to inhibit intracellular transport and thenwith 0.2 μg/ml of Alexa555–CTxB (CTxB, red) at 4 °C during 45min to allowmembrane binding. Next, cells were
transferred to 37 °C, in the presence (ﬁrst row) or absence (second-fourth row) of Alexa647–Tf (pseudo-colored green), to allow endocytic transport for 30min (ﬁrst and second row,
Alexa647–Tf and Rab11–GFP), 60 min (third row, GalNAc-T–YFP) or 120 min (fourth row, Iip33–GFP) and ﬁxed. Representative confocal sections of 1 μm taken parallel to the
coverslip are shown. Insets in merge panels show details at higher magniﬁcation. Scale bars: 10 μm. (C) CTx induces morphological change in CHO-K1GM1+ cells. CHO-K1GM1+ cells
were harvested and transferred to 35-mm dishes with coverslips. After 3 h, complete DMEM containing (+CTx, open circles) or not (−CTx, full circles) 2 μg/ml of CTx was added.
Coverslips were ﬁxed at different times and inspected microscopically to determine the percentage of cells with morphological changes. Values are the means±standard errors. (D)
Representative photographs of cells from each condition (−CTx and +CTx) at 5 h after toxin addition are shown.
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gesting that both ligands (CTx and antibodies to GM1) bind to
overlapping but also different GM1 molecules at the cell surface.
3.6. Antibody to GM1 and CTx are also differentially internalized in
COS-7 and neural cell lines
We next explore internalization and intracellular transport of
antibody to GM1 and CTx in the GM1-expressing COS-7 cells and
neuroblastoma cell lines Neuro2A and SH-SY5Y. Cells were
incubated with both proteins and the internalization was analyzed
at different times. Unexpectedly, we observed that antibody to
GM1 was only slightly internalized in the analyzed cell lines,
showing a clear PM localization (Fig. 7A and B, Ab to GM1). On the
other hand, CTxB was efﬁciently internalized in the three cell lines toaccumulate in a perinuclear organelle (Fig. 7A and B, CTxB),
colocalizing with a marker of recycling endosome (Fig. 7, Merges).
Almost identical results were obtained when Neuro2A and SH-SY5Y
cells were induced to differentiate by retinoic acid treatment (result
not shown). Altogether, these results strongly support a differential
internalization and intracellular sorting of the antibody to GM1 and
CTx.
It is known that the immobilization of molecules in speciﬁc sites of
the PM could be associated to regions with active endocytic processes
[35,41–44]. Thus, it is probable that the differences observed in the
internalization of antibody to GM1 in the analyzed cell lines could be
associated with dissimilar diffusional mobility of GM1 at the PM. In
order to demonstrate this association, we studied mobility of
Alexa488–antibody to GM1 complex at the PM by FRAP analysis
(Fig. 8A and B). We found that the half time of recovery (t1/2) and
Fig. 5. Internalized antibody to GM1 and CTxB partially colocalized in sorting and recycling endosomes in CHO-K1GM1+ cells. (A–C) Cells were incubated at 4 °C for 10 min to inhibit
intracellular transport. Then, they were incubated for another 45 min at 4 °C with antibody to GM1 (Ab to GM1, green) and Alexa555–CTxB (CTxB, red) in order to label GM1
ganglioside present at the cell surface. Afterwards, cells were ﬁxed (A), transferred to 16 °C for 1h (B) or transferred to 37 °C in complete DMEM supplemented with Alexa647–Tf
(pseudo-colored blue) for 30 min, ﬁxed and processed for immunodetection of antibody to GM1 (C). Representative confocal sections of 1 μm taken parallel to the coverslip are
shown. Insets in merge panels show details at higher magniﬁcation. Triple colocalization is visualized in white, and colocalization between red and blue is visualized in pink. Scale
bars: 10 μm. (D) In vivo analysis of colocalization between antibody to GM1 and CTx at recycling endosomes. Antibody to GM1–Alexa488 (green) and Alexa555–CTxB (red) were
applied to CHO-K1GM1+ cells at 4 °C for 45 min in phenol red-free DMEM, and then transferred to 37 °C for 30 min. Two representative cells are shown (ﬁrst panels). Magniﬁcation
(40× digital zoom) of the boxed area (recycling endosome area) is shown in the second panels (antibody to GM1, green) and in the third panels (CTxB, red). Fourth panels are
merged image from second and third panels. Arrowheads indicate regions of the recycling endosomes where antibody to GM1 and CTx colocalize (arrowhead number 3) and
segregate (arrowheads number 1, 5 and 6), and vesicles carrying only one of the GM1 binding proteins (arrowheads number 2 and 4). Scale bars: 10 μm.
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cantly different in COS-7 cells and Neuro2A cells than in CHO-K1GM1+
cells (Fig. 8C), suggesting a relationship between the efﬁciency ofendocytosis and lateral mobility of GM1 at the PM. The lower
diffusion rates of GM1 observed in PM of CHO-K1 cells are
compatible with the incorporation of GM1 into specialized
Fig. 6. Antibody to GM1 and CTx do not signiﬁcantly colocalize in PM and earliest endocytic vesicles close to the cell surface. CHO-K1GM1+ cells were incubated at 4 °C for 10 min and
thenwith Alexa488–antibody to GM1 and CTxB subunit–Alexa555 for another 45min at 4 °C. Then, cells were ﬁxed (A, PM staining) or incubated at 37 °C for 10min in order to restore
transport. Cell surface-bound antibody was then removed by acid stripping at 4 °C, and cells were extensively washed with cold PBS and ﬁxed (B, endocytic vesicles staining).
Epiﬂuorescence and TIRFM images were taken for each condition. Representative images are shown. Insets in merge panels show details at higher magniﬁcation. Scale bar: 10 μm.
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sense, we observed expression of caveolin-1 in CHO-K1 cells but
reduced levels in COS-7 and undetectable levels in Neuro2A and SH-
SY5Y cells (Fig. 9A). To strengthen the observation, the ectopic
expression of caveolin-1 in these cells lines clearly enhances the
endocytosis of antibody to GM1 (Fig. 9C) in Neuro2A and COS-7 cells
and CTxB in Neuro2A cells (Fig. 9D).
3.7. Antibody to GM1 obtained from a patient with GBS is speciﬁcally
internalized and trafﬁcked to the recycling endosome in GM1-expressing
CHO-K1 cells
We performed experiments to evaluate binding and trafﬁcking of
human IgG antibody to GM1 obtained from a patient with GBS [48] in
CHO-K1, COS-7, Neuro2A and SH-SY5Y cell lines. TLC immunostaining
analysis indicated that puriﬁed IgG antibody speciﬁcally bound toGM1
ganglioside and only slightly to GD1b (Fig. 10A). We observed that at4 °C the human antibody to GM1 bound to the PM of CHO-K1GM1+,
COS-7, Neuro2A and SH-SY5Y cells but not to PM of CHO-K1WT (Fig.
10B and C, 45 min 4 °C). After incubation at 37 °C, the antibody was
speciﬁcally internalized by CHO-K1GM1+ cells and accumulated in a
perinuclear area (Fig. 10C, CHO-K1GM1+, 30 min 37 °C) colocalizing
with Tf-positive recycling endosomes (result not shown). On the other
hand, the antibody was less internalized by COS-7, Neuro2A and SH-
SY5Y cell lines (Fig. 10C, COS-7, Neuro2A and SH-SY5Y, 30 min 37 °C).
Thus, the human IgG antibody to GM1 showed a similar behavior as
described above for the rabbit antibody to GM1, supporting the main
conclusions obtained with antibodies from experimental rabbit GBS.
4. Discussion
In this work, we used polyclonal antibody (IgG and IgM classes)
to monosialoganglioside GM1, obtained from rabbits with exper-
imental GBS induced by sensitization with GM1 ganglioside
Fig. 7. Antibody to GM1 and CTx are differentially internalized in COS-7 cells and neural cell lines. (A) COS-7 cells and neuroblastoma cell lines Neuro2A and SH-SY5Ywere incubated
at 4 °C to inhibit intracellular transport and then with antibody to GM1 (Ab to GM1, green) and Alexa555–CTxB (CTxB, red) at 4 °C during 45 min to allow membrane binding.
Afterwards, cells were transferred to 37 °C in complete medium supplemented with Alexa647–Tf (pseudo-colored blue) for 30 min, ﬁxed and processed for immunodetection of
antibody to GM1. Representative confocal sections of 1 μm taken parallel to the coverslip are shown. Insets inmerge panels show details at higher magniﬁcation. Triple colocalization
is visualized in white, and colocalization between red and blue is visualized in pink. Scale bars: 10 μm. (B) Number of cells (%) showing antibody to GM1 or CTx at the recycling
endosome (RE) after 30 min of endocytosis. Recycling endosome was identiﬁed by Tf staining. The values are mean±standard error from three independent experiments.
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epithelial and neural cells. Additionally, we compared intracellular
transport of antibody to GM1 with CTx, an extensively used GM1
binding toxin.
We found that, in CHO-K1GM1+ cells, the antibody to GM1 was
ﬁrst internalized to punctuate structures around the cytoplasm and
then accumulated in a pericentriolar compartment characterized asrecycling endosome. We also found that, after internalization, anti-
body to GM1 could be partially recovered from the extracellular
culture medium, indicating that the antibody was recycled back to
the PM from endocytic compartments. Additionally, antibody to
GM1 could not be detected at the TGN, ER and lysosomes at any
time after endocytosis. We also demonstrated that the association
of antibody to GM1 was unaffected even after 1 h at pH 5.5 or 6
Fig. 8. Lateral mobility of antibody to GM1 at the PM by FRAP analysis. Cells were incubated with Alexa488–antibody to GM1 for 20min at 4 °C in phenol red-free DMEM and subjected
to FRAP analysis using a 4-mm-diameter circular bleach region at zero time. (A) Representative images of FRAP experiments in CHO-K1GM1+ and COS-7 cells. White circle indicates
bleach region. (B) Fluorescence intensity over time plot for FRAP experiments in the epithelial cell lines CHO-K1GM1+ and COS-7, and neuroblastoma cell line Neuro2A. Fluorescence
recovery in the bleach region was recorded over time and normalized to the prebleach intensity. Approximately 13% of the membrane bound antibody at t=0 was endocytosed at
the end of the experiment (t=180 s). Data points aremeans±standard error and are representative of at least eight different FRAP experiments for each cell line. (C) Mobile fraction
(%Mobile), half time of recovery (t1/2) and diffusional mobility (D) of GM1–antibody to GM1 at the plasma membrane of CHO-K1GM1+, COS-7 and Neuro2A cells measured by FRAP.
Values are means±standard error.
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be disrupted in acidic endosomal compartments.
The internalization–recycling pathway described for polyclonal
antibody to GM1 in CHO-K1 cells is similar to the pathway described
for another antibody to ganglioside, themonoclonal antibody to disia-
loganglioside GD3, R24 [24]. Glycosphingolipid internalization and
recycling has been previously described. BODYPI-LacCer [18,49] and
C6-NBD-GlcCer [50,51] can recycle to the PM after being internalized.
Sofer et al. described that endocytosed C6-NBD-GM1 is mainly
recycled to PM [52]. Recycling has been also observed for sphingo-
myelin [53]. Taking these antecedents into consideration, it is highly
probable that the intracellular itinerary described for the antibody to
GM1 corresponds to the pathway followed by endogenous sphingo-
lipid while the internalization and trafﬁcking of CTx to the Golgiapparatus might be a reﬂection of the intracellular transport pathway
of the toxin rather than of the ganglioside.
Intracellular fate and transport of GM1 bound to CTx has been
widely studied in different cell lines [23,40,54–56] showing an
intracellular itinerary which is also conserved in CHO-K1GM1+ cells
(Fig. 4). Thus, results obtained in this study clearly show that two GM1
binding proteins (CTx and antibody) have different intracellular fate
in CHO-K1GM1+ cells. We observed that antibody and CTx were
mainly internalized in separate endosomes that later merge with
early endosomes, as already reported in the convergence of non-
clathrin- and clathrin-derived endosomes [57], which strongly
suggest that these GM1 binding proteins have preferential use for
speciﬁc endocytic mechanism. In this sense, it has been described that
CTx can use several endocytic mechanisms to reach endosomes
Fig. 9. Caveolin-1 increases antibody to GM1 internalization in COS-7 cells and in the neuroblastoma cell line Neuro2A. (A) Caveolin-1 protein levels in CHO-K1GM1+, COS-7, Neuro2A
and SH-SY5Y analyzed byWestern blotting of total cell extracts. Tubulin in the samemembrane was analyzed as control of protein loading. (B) Relative level of PM GM1 analyzed by
quantifying the ﬂuorescence of Alexa555–CTxB bound at 4 °C to CHO-K1GM1+, Neuro2A and COS-7 cells transfected (Caveolin 1) or not (Control) with caveolin-1–GFP. (C and D)
CHO-K1GM1+, Neuro2A and COS-7 cells transfected (Caveolin 1) or not (Control) with caveolin-1–GFPwere incubated at 4 °C to inhibit intracellular transport and thenwith antibody
to GM1 (Ab to GM1, C) or Alexa555–CTxB (CTxB, D) at 4 °C during 45 min to allow membrane binding. Next, cells were washed and transferred to 37 °C to allow endocytic transport
for 30min. Cell surface-bound antibody or toxin were then removed by acid stripping at 4 °C and cell ﬁxed. The relative level of intracellular antibody to GM1 and CTxB was analyzed
by quantifying both the ﬂuorescence of a secondary antibody against the antibody to GM1 and Alexa555–CTxB. For each cell line, the ﬂuorescence intensity of control cells was
arbitrarily taken as 1. The values are mean±standard error from two independent experiments. ⁎, Pb0.05.
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limited to speciﬁc routes, as it has been described for ﬂuorescent or
radioactive glycosphingolipids [15,16,47,60]. Independently of the
endocytic mechanism used, differential cell surface binding or
segregation between antibody to GM1 and CTx must take place at
the PM which results in a selective endocytosis to a subset of
endosomes. In this regard, experiments shown in Fig. S4 indicate that
CTx does not block all antibody binding sites at the PM, suggesting
that the toxin and immunoglobulins to GM1 bind to overlapping but
also different GM1 molecules at the cell surface which could explain
the differential subsequent intracellular trafﬁcking of these ligands.
Interestingly, differential cell surface globotriaosyl ceramide (Gb3)
binding between antibodies to Gb3 and verotoxin-1 (Shiga toxin) has
been also reported [61]. Moreover, it was recently demonstrated that
verotoxin-1 and verotoxin-2, which are differentially endocytosed
and trafﬁcked in Vero cells, bind to both distinct and overlapping
subpopulations of membrane Gb3 [62]. By in vivo ﬂuorescent confocal
analysis we also observed that co-endocytosed antibody to GM1 and
CTx partially colocalized at the recycling endosome from where the
antibody to GM1 is recycled to PM. It was reported that CTx can also
be recycled to the PM and released into the culture medium [63], as
observed for antibody to GM1. However, neither CTx nor antibodies to
CTx were detected into the culture medium after internalization in
CHO-K1GM1+ cells (Fig. S6A and B). Regarding the fraction of toxin
colocalized with GM1 antibody at the recycling endosomes, it couldrepresent a pool recycling to PM. On the other hand, the pool of CTx
which does not colocalize with the antibody at the recycling
endosomes probably moves to the Golgi complex. In agreement
with this assumption, experiments performed in another laboratory
using the same GM1-expressing CHO-K1 clone demonstrated a
remarkable inhibition of the transport of CTx from early endosomes
to the Golgi apparatus in Rab22a-expressing cells [64], probably by
affecting the trafﬁcking from early to recycling endosomes [64,65].
We next analyzed internalization and trafﬁcking of antibody to
GM1 in other cell types. To our surprise, we found that internalization
of antibody to GM1 was considerably reduced (especially to the re-
cycling endosome) in the GM1-expressing COS-7 cells and the neuro-
blastoma cell lines Neuro2A and SH-SY5Y. However, CTx was indeed
internalized and sorted to Tf-positive intracellular organelles in all
analyzed cell lines, supporting a differential internalization and
sorting of both GM1-binding proteins. Moreover, the observed diffe-
rences could not be associated to the levels of GM1 in membranes
from all analyzed cell lines (Fig. S1B).
Biophysical studies using model membranes demonstrate that CTx
can perturb membrane structure [66] and shift GM1 to a liquid
ordered phase [67]. At the cellular level, clustering of GM1 molecules
induced by CTx could induce a segregation of toxin–GM1 complex
into specialized membrane domains and/or to a modiﬁcation of
membrane properties, resulting in a particular endocytosis and intra-
cellular sorting. It has been demonstrated that Gb3 binding of Shiga
Fig. 10. Binding and internalization of human antibody (IgG) to GM1. (A) Binding of human antibody to GM1 (Ab to GM1, IgG) and structurally related gangliosides (GA1, GD1a,
GD1b and GT1b) was tested by TLC immunostaining. Standard gangliosides were visualized by orcinol staining. (B) CHO-K1WT cells were incubated at 4 °C to inhibit intracellular
transport and then with human antibody to GM1 (Ab to GM1, IgG) at 4 °C during 45 min to allow membrane binding. Next, cells were washed, ﬁxed (45 min 4 °C) or transferred
to 37 °C in media with Alexa647–Tf (as a positive control of endocytosis) to allow endocytic transport for 30 min and ﬁxed. (C) CHO-K1GM1+, COS-7 cells and neuroblastoma cell
lines Neuro2A and SH-SY5Y were incubated at 4 °C to inhibit intracellular transport and then with human antibody to GM1 (IgG) at 4 °C during 45 min to allow membrane
binding. Next, cells were washed, ﬁxed (45 min 4 °C) or transferred to 37 °C to allow endocytic transport for 30 min and ﬁxed. Representative confocal sections of 1 μm from the
different times taken parallel to the coverslip are shown. Insets in panels show details at higher magniﬁcation. Antibody to GM1 was detected by using TRITC-conjugated anti-
human IgG. Scale bars: 10 μm.
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clustering, leading to the formation of tubular membrane invagina-
tions that could stimulate its uptake into cells [68]. Moreover, the
simian virus 40, a GM1 binding virus that has the ability to be sorted to
the ER [12], can bind up to ﬁve GM1 molecules at a time [69], sup-
porting the idea that clustering may be critical for retrograde trans-
port to the ER. In this study, we used afﬁnity puriﬁed IgG and IgM
antibodies to GM1. Whereas IgG antibody can bind only one or two
GM1 molecules, IgM antibody can cluster several ganglioside
molecules. Nevertheless, puriﬁed IgM antibody to GM1 followed
almost the same intracellular itinerary as IgG antibody to GM1 did
(Fig. 3 and Fig. S3), suggesting that clustering by itself seems not to be
mandatory for endocytosis and retrograde transport of GM1 gangli-
oside. In agreement with these results, it has been demonstrated that
CTx mutants with decreased ability to cluster GM1 are internalized
and induced cAMP synthesis [22,35,70]. Thus, it is highly probable
that other parameters like size and geometry of the clustered CTx–
GM1 complex and/or structural information present in the toxin
could be relevant to induce its trafﬁcking to ER in contrast to the
intracellular itinerary followed by the antibody–GM1 complex.
We observed that internalization of antibody–GM1 complex was
higher in CHO-K1GM1+ cells than in the other analyzed cell lines
(COS-7, Neuro2A and SH-SY5Y), while CTxB was efﬁciently interna-lized in all cell lines. These results probably are indicating differences
in the GM1 organization at the PM of analyzed cell lines, which can
explain the selective endocytosis of antibody to GM1 and CTx.
Photobleaching experiments revealed that diffusion of antibody–
GM1 complex was higher in the PM of cells that internalized less
antibody. A decrease in the lateral membrane mobility of endocytic
proteins and lipids at the sites of internalization has been previously
observed. For instance, PM of Saccharomyces cerevisiae contains large
stable protein assemblies named eisosomes that mark endocytic sites
of lipids and proteins [44]. In addition, ganglioside GM1 and other
sphingolipids have been observed enriched in caveolae, stable endo-
cytic structures at the PM [45–47]. In this sense, we observed
expression of caveolin-1 in CHO-K1 cells but reduced levels in COS-7
and undetectable levels in Neuro2A and SH-SY5Y cells (Fig. 9A).
Supporting the role of caveolae in the internalization of the antibody
to GM1, the ectopic expression of caveolin-1 in COS-7 and Neuro2A
cells considerably enhanced the endocytosis of antibody–glycolipid
complex without affecting the PM binding and internalization of CTx
in CHO-K1GM1+ and COS-7 cells (Fig. 9C and D). In addition,
caveolin-1 overexpression signiﬁcantly enhanced the internalization
of CTxB in Neuro2A (Fig. 9D). It is also known that membrane lipid
microdomains (“lipid rafts”) have a reduced lateral mobility at the
PM [35,42] which also suggest that the lower diffusion rates of GM1
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incorporation of GM1 into these specialized membrane domains.
Taken into consideration all these antecedents, it is highly probable
that the lower membrane diffusion of antibody–GM1 complex
observed in CHO-K1GM1+ cells represents a transient sequestration
of GM1 ganglioside in domains or sites specialized for endocytosis,
which could be responsible for the increased internalization of
antibody to GM1 observed in this epithelial cell line.
Finally, the experimental data described in this work are likely to
be of considerable biological and immunological signiﬁcance since
they provide for the ﬁrst time evidences about internalization,
intracellular fate and endocytic pathways of antibody to GM1
obtained from rabbits with experimental GBS. Moreover, they
provide the basis to gain further insights into the mechanisms that
operates in the pathological effects of neuropathy-associated anti-
bodies and intracellular trafﬁcking of CTx, the principal virulence
factor of epidemic Vibrio cholerae strains.
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